Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.97B |
| FY2017, ended Dec 31, 2017 | $10.3B |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $16.3B |
| FY2020, ended Dec 31, 2020 | $23.3B |
| FY2021, ended Dec 31, 2021 | $44.0B |
| FY2022, ended Dec 31, 2022 | $40.0B |
| FY2023, ended Dec 31, 2023 | $73.3B |
| FY2024, ended Dec 31, 2024 | $131B |
| FY2025, ended Dec 31, 2025 | $114B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $82.4B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.04B |
| FY2017, ended Dec 31, 2017 | $3.56B |
| FY2018, ended Dec 31, 2018 | $2.40B |
| FY2019, ended Dec 31, 2019 | $4.22B |
| FY2020, ended Dec 31, 2020 | $4.23B |
| FY2021, ended Dec 31, 2021 | $16.2B |
| FY2022, ended Dec 31, 2022 | $5.70B |
| FY2023, ended Dec 31, 2023 | $14.5B |
| FY2024, ended Dec 31, 2024 | $21.9B |
| FY2025, ended Dec 31, 2025 | $19.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $309M | −$1.50B |
| FY2017, ended Dec 31, 2017 | $1.02B | −$3.63B |
| FY2018, ended Dec 31, 2018 | $1.13B | −$7.71B |
| FY2019, ended Dec 31, 2019 | $2.01B | −$5.88B |
| FY2020, ended Dec 31, 2020 | $2.00B | — |
| FY2021, ended Dec 31, 2021 | $4.73B | — |
| FY2022, ended Dec 31, 2022 | −$522M | — |
| FY2023, ended Dec 31, 2023 | $3.73B | — |
| FY2024, ended Dec 31, 2024 | $3.08B | — |
| FY2025, ended Dec 31, 2025 | $2.37B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.15B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.51B |
| FY2017, ended Dec 31, 2017 | $1.88B |
| FY2018, ended Dec 31, 2018 | $1.75B |
| FY2019, ended Dec 31, 2019 | $2.35B |
| FY2020, ended Dec 31, 2020 | $5.36B |
| FY2021, ended Dec 31, 2021 | $10.5B |
| FY2022, ended Dec 31, 2022 | $13.4B |
| FY2023, ended Dec 31, 2023 | $20.8B |
| FY2024, ended Dec 31, 2024 | $15.4B |
| FY2025, ended Dec 31, 2025 | $17.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.2B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.7B |
| FY2017, ended Dec 31, 2017 | $21.4B |
| FY2018, ended Dec 31, 2018 | $22.6B |
| FY2019, ended Dec 31, 2019 | $27.2B |
| FY2020, ended Dec 31, 2020 | $33.5B |
| FY2021, ended Dec 31, 2021 | $36.9B |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 98.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 453M |
| FY2017, ended Dec 31, 2017 | 487M |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | 559M |
| FY2020, ended Dec 31, 2020 | 577M |
| FY2021, ended Dec 31, 2021 | 591M |
| FY2022, ended Dec 31, 2022 | 861M |
| FY2023, ended Dec 31, 2023 | 885M |
| FY2024, ended Dec 31, 2024 | 888M |
| FY2025, ended Dec 31, 2025 | 892M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 898M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $265M | — | — |
| FY2017, ended Dec 31, 2017 | $0 | $335M | — | $94.2M |
| FY2018, ended Dec 31, 2018 | $173M | $332M | — | — |
| FY2019, ended Dec 31, 2019 | $72.1M | $298M | $0 | — |
| FY2020, ended Dec 31, 2020 | $246M | $327M | $0 | — |
| FY2021, ended Dec 31, 2021 | $270M | $530M | $38.5M | — |
| FY2022, ended Dec 31, 2022 | $347M | $730M | $0 | — |
| FY2023, ended Dec 31, 2023 | $290M | $618M | $0 | — |
| FY2024, ended Dec 31, 2024 | $0 | $746M | — | — |
| FY2025, ended Dec 31, 2025 | $3.36M | $722M | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $233M | $771M | — | — |
Valuation
At current price- Market Cap
- $82.5B
- P/E
- 26.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.9×
- Price / Book
- 2.7×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $21.3B
- Revenue Growth YoY
- 31.1%
- Revenue CAGR 3Y
- 50.6%
- Revenue CAGR 5Y
- 35.7%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 53.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 14.8%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 10.6%
Earnings
Trailing 12 months- Net Income
- $3.15B
- EPS (diluted)
- —
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $21.2B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $414B
- Total Liabilities
- $334B
- Shareholders' Equity
- $31.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.49B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $0.76
- Beta (5Y)
- 1.83
Every ratio is calculated from the company’s reported figures.